首页 | 本学科首页   官方微博 | 高级检索  
     

良恶性胸腔积液的临床特征及预测因素分析
引用本文:秦 湧,朱祎娜,崔 进. 良恶性胸腔积液的临床特征及预测因素分析[J]. 现代肿瘤医学, 2015, 0(9): 1236-1238. DOI: 10.3969/j.issn.1672-4992.2015.09.19
作者姓名:秦 湧  朱祎娜  崔 进
作者单位:南京医科大学第二附属医院呼吸内科,江苏 南京 210011
摘    要:目的:对比分析良恶性胸腔积液的临床特征,筛选恶性胸腔积液可能的预测因素。方法:收集良性胸腔积液患者30人和恶性胸腔积液患者32人的临床资料,分析胸腔积液及血液学相关指标(胸腔积液物理性状、胸腔积液和血液学生化、肿瘤标志物)。结果:恶性胸腔积液患者的年龄明显高于良性胸腔积液患者,但二者在性别分布上无差异。恶性胸腔积液的乳酸脱氢酶(LDH)、腺苷脱氨酶(ADA)、γ-干扰素(γ-IFN)显著低于良性胸腔积液,而癌胚抗原(CEA)、糖类抗原(CA19-9)、神经特异性烯醇化酶(NSE)显著高于良性胸腔积液(P均<0.05)。两组患者血液LDH、ADA、CEA、CA19-9的差异也具有统计学意义。条件Logistic回归分析发现CEA>10ng/ml、血性胸腔积液、ADA<15U/ml、CA19-9>20U/ml为恶性胸腔积液的预测因素。结论:非肿瘤标志物(如胸水颜色、ADA值)也有助于胸腔积液性质的判断。恶性胸腔积液的预测作用由大到小依次为CEA、血性胸腔积液、ADA、CA19-9。

关 键 词:胸腔积液  肺癌  肿瘤标志物

Clinical characteristics and predictors of malignant pleural effusion and non - malignant pleural effusion
Qin Yong,Zhu Yina,Cui Jin. Clinical characteristics and predictors of malignant pleural effusion and non - malignant pleural effusion[J]. Journal of Modern Oncology, 2015, 0(9): 1236-1238. DOI: 10.3969/j.issn.1672-4992.2015.09.19
Authors:Qin Yong  Zhu Yina  Cui Jin
Affiliation:Department of Respiratory Medicine,The Second Affiliated Hospital of Nanjing Medical University,Jiangsu Nanjing 210011,China.
Abstract:Objective:To compare the clinical characteristics between malignant pleural effusion (MPE) and non-malignant pleural effusion (NMPE) and the predictive factors of MPE. Methods:A total of 32 MPE patients and 30 NMPE patients were enrolled in this study.The parameters (physical characteristics,biochemical index and tumor markers) of pleural effusion and plasma were analyzed. Results:The MPE patients were older than NMPE patients.There were remarkably lower LDH,ADA and γ-IFN in MPE than those in NMPE.The MPE patients had a significantly higher CEA,CA19-9,NSE in both pleural effusion and plasma than NMPE patients.CEA>10ng/ml,bloody pleural effusion,ADA<15U/ml and CA19-9>20U/ml were the predictive factors for MPE.Conclusion:The non-tumor markers such as ADA are of value to identify the nature of pleural effusion.The predictive power for MPE are CEA,bloody pleural effusion,ADA and CA19-9 in sequence.
Keywords:pleural effusion  lung cancer  tumor marker
本文献已被 万方数据 等数据库收录!
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号